SCHEMBL1016535

SCHEMBL1016535

[CH2]c1cc(Cl)ccc1NC(=O)N(C)C

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
HTT P42858 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
APEX1 P27695 1/20 0.46
MAPT P10636 1/20 0.44
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.41
FSCN1 Q16658 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030047 0.83 RAB9A (0.64) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL11801105 0.81 MAPK1 (0.56) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL11135310 0.81 TSHR (0.56) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL20540420 0.79 MEN1 (0.61) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL7254129 0.78 KCNMA1 (0.58) TSHRHTTNPC1RAB9AMAPT
SCHEMBL10810548 0.76 TSHR (0.50) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL10813601 0.76 ABL1 (0.50) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL10706727 0.76 TSHR (0.50) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL1019310 0.76 ALDH1A1 (0.50) TSHRHTTNPC1RAB9AAPEX1
SCHEMBL8927627 0.75 ALDH1A1 (0.49) TSHRHTTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271624-A1 IMINOPYRIDINE DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-01-12 EP disclosed
WO-2009131245-A1 IMINOPYRIDINE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-29 WO disclosed